Efficacy and safety findings from DREAM: A phase III study of DHP107 (oral paclitaxel) vs IV paclitaxel in patients with gastric cancer after failure of first-line chemotherapy.

Yoon-Koo Kang; Min-Hee Ryu; Se Hoon Park; Sook Ryun Park; Jong Gwang Kim; Jin Won Kim; Sang Hee Cho; Young Iee Park; Sun Young Rha; Myoung Joo Kang; Jae Yong Cho; Seok Yun Kang; Young Seon Hong; Baek-Yeol Ryoo; Byung-Ho Nam; Yeong Woo Jo; Koung Eun Yoon; Sang Cheul Oh

doi:10.1200/jco.2016.34.15_suppl.4016

Efficacy and safety findings from DREAM: A phase III study of DHP107 (oral paclitaxel) vs IV paclitaxel in patients with gastric cancer after failure of first-line chemotherapy.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.4016 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 4016-4016 ◽

Cited By ~ 3

Author(s):

Yoon-Koo Kang ◽

Min-Hee Ryu ◽

Se Hoon Park ◽

Sook Ryun Park ◽

Jong Gwang Kim ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Iii ◽

Efficacy And Safety ◽

First Line ◽

Phase Iii Study ◽

Line Chemotherapy ◽

Oral Paclitaxel

Download Full-text

Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy

Annals of Oncology ◽

10.1093/annonc/mdy055 ◽

2018 ◽

Vol 29 (5) ◽

pp. 1220-1226 ◽

Cited By ~ 10

Author(s):

Y.-K. Kang ◽

M.-H. Ryu ◽

S.H. Park ◽

J.G. Kim ◽

J.W. Kim ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Iii ◽

Efficacy And Safety ◽

First Line ◽

Phase Iii Study ◽

Line Chemotherapy ◽

Oral Paclitaxel

Download Full-text

A phase III study to compare efficacy and safety of DHP107 (oral paclitaxel) versus IV paclitaxel in patients with metastatic or recurrent gastric cancer after failure of first-line chemotherapy (DREAM).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.tps4138 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. TPS4138-TPS4138

Author(s):

Sang Cheul Oh ◽

Min-Hee Ryu ◽

Se Hoon Park ◽

Baek-Yeol Ryoo ◽

Sook Ryun Park ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Iii ◽

Efficacy And Safety ◽

First Line ◽

Recurrent Gastric Cancer ◽

Phase Iii Study ◽

Line Chemotherapy ◽

Oral Paclitaxel

Download Full-text

6600 POSTER A Randomized, Multicenter, Open-label, Phase III Study to Compare the Efficacy and Safety of Capecitabine Plus Paclitaxel Followed by Capecitabine Maintenance (PX-X) With Capecitabine Plus Cisplatin (XP) as a First-line Chemotherapy for Recurrent or Metastatic Gastric Cancer (PAC-C Study)

European Journal of Cancer ◽

10.1016/s0959-8049(11)71911-6 ◽

2011 ◽

Vol 47 ◽

pp. S471-S472

Author(s):

X. Zhang ◽

L. Shen ◽

Z. Lu ◽

B. Hu ◽

Q. Fan ◽

...

Keyword(s):

Gastric Cancer ◽

Metastatic Gastric Cancer ◽

Phase Iii ◽

Efficacy And Safety ◽

First Line ◽

Open Label ◽

Open Label Phase ◽

Phase Iii Study ◽

Line Chemotherapy

Download Full-text

1374P A randomized phase III study to compare efficacy and safety between combination therapy and monotherapy as first-line chemotherapy in elderly patients with advanced gastric cancer (KCSG ST13-10)

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1483 ◽

2021 ◽

Vol 32 ◽

pp. S1041

Author(s):

I. Choi ◽

K-W. Lee ◽

D.Y. Zang ◽

M.H. Ryu ◽

H.S. Han ◽

...

Keyword(s):

Gastric Cancer ◽

Combination Therapy ◽

Elderly Patients ◽

Advanced Gastric Cancer ◽

Phase Iii ◽

Efficacy And Safety ◽

First Line ◽

Phase Iii Study ◽

Line Chemotherapy

Download Full-text

A phase III study to compare the efficacy and safety of paclitaxel versus irinotecan in patients with metastatic or recurrent gastric cancer who failed in first-line therapy (KCSG ST10-01)

Annals of Oncology ◽

10.1093/annonc/mdy282.064 ◽

2018 ◽

Vol 29 ◽

pp. viii228-viii229

Author(s):

K.-W. Lee ◽

C.H. Maeng ◽

T.-Y. Kim ◽

D.Y. Zang ◽

Y.H. Kim ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Iii ◽

Efficacy And Safety ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Recurrent Gastric Cancer ◽

Phase Iii Study

Download Full-text

Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)

Gastric Cancer ◽

10.1007/s10120-011-0009-5 ◽

2011 ◽

Vol 14 (1) ◽

pp. 72-80 ◽

Cited By ~ 97

Author(s):

Hiroyuki Narahara ◽

Hiroyasu Iishi ◽

Hiroshi Imamura ◽

Akira Tsuburaya ◽

Keisho Chin ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Iii ◽

Line Treatment ◽

Efficacy And Safety ◽

First Line ◽

Cancer Study ◽

Gastric Cancer Study ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

AGO-OVAR 16: A phase III study to evaluate the efficacy and safety of pazopanib (PZ) monotherapy versus placebo in women who have not progressed after first line chemotherapy for epithelial ovarian, fallopian tube, or primary peritoneal cancer—Overall survival (OS) results.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.5518 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 5518-5518 ◽

Cited By ~ 4

Author(s):

Ignace Vergote ◽

Lars Christian Hanker ◽

Anne Floquet ◽

Joern Rau ◽

Jae-Weon Kim ◽

...

Keyword(s):

Overall Survival ◽

Fallopian Tube ◽

Phase Iii ◽

Efficacy And Safety ◽

First Line ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Phase Iii Study ◽

Line Chemotherapy

Download Full-text

A phase III study of TAS-118 plus oxaliplatin versus S-1 plus cisplatin as first-line chemotherapy in patients with advanced gastric cancer (SOLAR study)

Annals of Oncology ◽

10.1093/annonc/mdz183.002 ◽

2019 ◽

Vol 30 ◽

pp. iv153 ◽

Cited By ~ 4

Author(s):

Y. Kang ◽

K. Chin ◽

H. Chung ◽

S. Kadowaki ◽

S. Oh ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Iii ◽

First Line ◽

Phase Iii Study ◽

Line Chemotherapy

Download Full-text

A Phase III Study to Compare the Efficacy and Safety of Paclitaxel Versus Irinotecan in Patients with Metastatic or Recurrent Gastric Cancer Who Failed in First‐line Therapy (KCSG ST10‐01)

The Oncologist ◽

10.1634/theoncologist.2018-0142 ◽

2018 ◽

Vol 24 (1) ◽

pp. 18 ◽

Cited By ~ 3

Author(s):

Keun‐Wook Lee ◽

Chi Hoon Maeng ◽

Tae‐You Kim ◽

Dae Young Zang ◽

Yeul Hong Kim ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Iii ◽

Efficacy And Safety ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Recurrent Gastric Cancer ◽

Phase Iii Study

Download Full-text

A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC

Case Medical Research ◽

10.31525/ct1-nct04033354 ◽

2019 ◽

Author(s):

Keyword(s):

Stage Iiib ◽

Phase Iii ◽

Line Treatment ◽

Efficacy And Safety ◽

First Line ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text